BioNTech posts $721M loss in 2024 due to low demand for COVID-19 vaccines

Report24

Far Right

Factuality

Ownership

That's what happened with the billion-dollar blessing: crisis winner BioNTech is back in the red again. Profit from the controversial mRNA vaccine is shrinking in itself. Instead, the company recorded a net loss of EUR 700 million in 2024. Now all hopes are set on mRNA therapies against cancer. As the new big pharmaceutical test rabbits will probably succeed? The money blessing from planning times cannot be maintained: BioNTech now wants to make…

Tagesschau

Center

Factuality

Ownership

The Corona vaccine brought BioNTech billions of profits. However, the company is now recording losses. Now the company wants to reduce hundreds of jobs.

www.t-online.de

Lean Left

Factuality

Ownership

The former Corona overflyer Biontech is now writing red numbers, also due to high investments in expensive clinical trials.

focus.de

Center

Factuality

Ownership

The biotech company Biontech has earned billions with its Corona vaccine. Mainzers put the money into the development of new drugs. But they still need a lot of time - and the revenues are shrinking.

merkur.de

Center

Factuality

Ownership

The Mainz-based company Biontech is facing a change. Despite financial challenges, they continue to invest in innovative cancer therapies.